Skip to Main Content

Dyadic International, Inc.

DYAI Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
DYAI Income Statement
DYAI Balance Sheet
DYAI Cash Flow

Recent trades of DYAI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
DYAI Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
DYAI Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DYAI Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by DYAI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $20,000 Aug 14, 2007 Issue: Energy/Nuclear

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Nicotinamide riboside production in filamentous fungi May. 14, 2024
  • Patent Title: Production of flu vaccine in Aug. 29, 2023
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Dec. 23, 2014
  • Patent Title: Transformation system in the field of filamentous fungal hosts Oct. 28, 2014
  • Patent Title: Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi Mar. 25, 2014
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Mar. 18, 2014
  • Patent Title: Bx11 enzymes having xylosidase activity Oct. 08, 2013
  • Patent Title: Methods and compositions for degradation of lignocellulosic material Nov. 06, 2012
  • Patent Title: Transformation system in the field of filamentous fungal hosts Sep. 18, 2012
  • Patent Title: Fungal enzymes Apr. 12, 2011
  • Patent Title: Expression-regulating sequences and expression products in the field of filamentous fungi Mar. 15, 2011
  • Patent Title: Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose Feb. 08, 2011
  • Patent Title: High-throughput screening of expressed dna libraries in filamentous fungi Sep. 14, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of DYAI in WallStreetBets Daily Discussion

DYAI News

Recent insights relating to DYAI

CNBC Recommendations

Recent picks made for DYAI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DYAI

DYAI Top Shareholders
Shareholder
Shares Held
DYAI Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DYAI Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DYAI Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top